Northwest & Ethical Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,114
| Closed | -$5.51M | – | 496 |
|
|
2024
Q3 | $5.51M | Sell |
17,114
-3,143
| -16% | -$1.03M | 0.15% | 172 |
|
|
2024
Q2 | $6.33M | Sell |
20,257
-10,318
| -34% | -$3.03M | 0.18% | 150 |
|
|
2024
Q1 | $8.69M | Sell |
30,575
-3,903
| -11% | -$1.14M | 0.25% | 124 |
|
|
2023
Q4 | $9.93M | Sell |
34,478
-153
| -0.4% | -$41.7K | 0.31% | 112 |
|
|
2023
Q3 | $9.31M | Buy |
34,631
+8,949
| +35% | +$2.23M | 0.31% | 109 |
|
|
2023
Q2 | $5.7M | Sell |
25,682
-2,007
| -7% | -$466K | 0.18% | 160 |
|
|
2023
Q1 | $6.69M | Hold |
27,689
| – | – | 0.22% | 138 |
|
|
2022
Q4 | $7.27M | Buy |
27,689
+4,265
| +18% | +$1.14M | 0.25% | 129 |
|
|
2022
Q3 | $5.28M | Sell |
23,424
-299
| -1% | -$72.5K | 0.21% | 145 |
|
|
2022
Q2 | $5.77M | Buy |
23,723
+394
| +2% | +$96.6K | 0.22% | 138 |
|
|
2022
Q1 | $5.64M | Sell |
23,329
-296
| -1% | -$68K | 0.18% | 149 |
|
|
2021
Q4 | $5.31M | Buy |
23,625
+4,733
| +25% | +$999K | 0.16% | 158 |
|
|
2021
Q3 | $4.02M | Sell |
18,892
-164
| -0.9% | -$37.7K | 0.13% | 182 |
|
|
2021
Q2 | $4.64M | Sell |
19,056
-10,519
| -36% | -$2.59M | 0.15% | 168 |
|
|
2021
Q1 | $7.36M | Sell |
29,575
-22,530
| -43% | -$5.38M | 0.26% | 116 |
|
|
2020
Q4 | $12M | Sell |
52,105
-1,029
| -2% | -$237K | 0.46% | 70 |
|
|
2020
Q3 | $13.5M | Sell |
53,134
-1,846
| -3% | -$457K | 0.59% | 48 |
|
|
2020
Q2 | $13M | Buy |
54,980
+5,833
| +12% | +$1.33M | 0.62% | 40 |
|
|
2020
Q1 | $9.96M | Buy |
49,147
+878
| +2% | +$192K | 0.58% | 43 |
|
|
2019
Q4 | $11.6M | Sell |
48,269
-12,216
| -20% | -$2.69M | 0.52% | 48 |
|
|
2019
Q3 | $11.7M | Sell |
60,485
-551
| -0.9% | -$106K | 0.57% | 40 |
|
|
2019
Q2 | $11.2M | Buy |
61,036
+973
| +2% | +$174K | 0.56% | 43 |
|
|
2019
Q1 | $11.4M | Sell |
60,063
-194
| -0.3% | -$37K | 0.59% | 38 |
|
|
2018
Q4 | $11.7M | Buy |
60,257
+12,848
| +27% | +$2.51M | 0.7% | 31 |
|
|
2018
Q3 | $9.83M | Buy |
47,409
+1,670
| +4% | +$329K | 0.62% | 34 |
|
|
2018
Q2 | $8.44M | Sell |
45,739
-1,773
| -4% | -$314K | 0.56% | 43 |
|
|
2018
Q1 | $8.1M | Buy |
47,512
+275
| +0.6% | +$50.5K | 0.54% | 43 |
|
|
2017
Q4 | $8.21M | Sell |
47,237
-1,070
| -2% | -$189K | 0.53% | 43 |
|
|
2017
Q3 | $9.01M | Buy |
48,307
+2,369
| +5% | +$420K | 0.56% | 34 |
|
|
2017
Q2 | $7.91M | Sell |
45,938
-33,770
| -42% | -$5.49M | 0.54% | 37 |
|
|
2017
Q1 | $13.1M | Buy |
79,708
+1,850
| +2% | +$307K | 0.89% | 20 |
|
|
2016
Q4 | $11.4M | Sell |
77,858
-8,378
| -10% | -$1.26M | 0.78% | 25 |
|
|
2016
Q3 | $14.4M | Buy |
86,236
+65,323
| +312% | +$11M | 1.01% | 19 |
|
|
2016
Q2 | $3.18M | Buy |
20,913
+11,036
| +112% | +$1.72M | 0.24% | 104 |
|
|
2016
Q1 | $1.48M | Buy |
+9,877
| New | +$1.47M | 0.1% | 154 |
|
Other funds holding AMGN
Northwest & Ethical Investments's AMGN Position: Q4 2024 in Review
Northwest & Ethical Investments sold out of Amgen (AMGN) in Q4 2024, closing a stake of 17,114 shares — an estimated $5.51M sold.
Northwest & Ethical Investments first reported a position in AMGN in Q1 2016 and held it in 35 quarters. The position peaked at $14.4M in Q3 2016. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Northwest & Ethical Investments reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Northwest & Ethical Investments sold 17,114 Amgen shares in Q4 2024, an estimated $5.51M.
- Northwest & Ethical Investments first reported a position in Amgen in Q1 2016 and held it in 35 quarters.
- Northwest & Ethical Investments's Amgen position peaked at $14.4M in Q3 2016.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Northwest & Ethical Investments's 13F filing for Q4 2024, filed 11 Feb 2025.